Form 483

Venus Pharmaceuticals International, Inc. Form 483, 2011-07-12

FDA issued a Form 483 to Venus Pharmaceuticals International, Inc. on 2011-07-12 with 11 public-safe observations.

483· Form 483 issued11 observations

Venus Pharmaceuticals International, Inc. · Hauppauge, United States · Issued July 12, 2011

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Jul 2011
21 CFR 110.40(a)

Materials and workmanship

Cited by Meredith P Soehl

12 Jul 2011
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Meredith P Soehl

12 Jul 2011
21 CFR 111.75(a)(2)(ii)(A)

Component - qualify supplier

Cited by Meredith P Soehl

12 Jul 2011
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Meredith P Soehl

12 Jul 2011
21 CFR 111.77(a)

Specifications not met - reject, quality control

Cited by Meredith P Soehl

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 110.40(a)Cited across public-safe Form 483 observations1x
21 CFR 111.103Cited across public-safe Form 483 observations1x
21 CFR 111.155(e)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.260(c)Cited across public-safe Form 483 observations1x
21 CFR 111.325(b)(2)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.605Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x
21 CFR 111.77(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere